15 minutes ago
In this interview, Perez discusses data linking monocyte epigenetic age acceleration to non-somatic depressive symptoms.
1 hour ago
COBRA findings suggest 1 day of antibiotic treatment is preferred in acute cholangitis after adequate biliary drainage compared to longer guidelines.
2 hours ago
Edward Barnes, MD, MPH, explains mirikizumab’s strong remission and durable response in Crohn’s disease patients after anti-TNF failure, supporting second-line use.
2 hours ago
Maria Abreu, MD, breaks down efficacy and safety data for dual-target co-antibody JNJ-4804, offering a potential new option for heavily pretreated UC patients.
3 hours ago
Catch up on key clinician insights, major FDA decisions, groundbreaking trial results, and more.